Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke

Secondary prevention with NOACs after stroke might be more beneficial than a VKA by reducing recurrent infarct volume.